RT @EmmesCorp: August is #NationalEyeExamMonth dedicated to importance of eye health & safety! SCORE2 had its 1st ppt in Sept 2014 & is sti…
RT @EmmesCorp: August is #NationalEyeExamMonth dedicated to importance of eye health & safety! SCORE2 had its 1st ppt in Sept 2014 & is sti…
August is #NationalEyeExamMonth dedicated to importance of eye health & safety! SCORE2 had its 1st ppt in Sept 2014 & is still ongoing w/ 7 papers published & more in development. The primary paper is in top 5% of all research outputs scored by
RT @JAMAOphth: At @ARVOinfo? Visit Booth 913 to get a copy of "Effect of Bevacizumab vs Aflibercept on Visual Acuity among #Patients With M…
RT @JAMAOphth: At @ARVOinfo? Visit Booth 913 to get a copy of "Effect of Bevacizumab vs Aflibercept on Visual Acuity among #Patients With M…
RT @JAMAOphth: At @ARVOinfo? Visit Booth 913 to get a copy of "Effect of Bevacizumab vs Aflibercept on Visual Acuity among #Patients With M…
At @ARVOinfo? Visit Booth 913 to get a copy of "Effect of Bevacizumab vs Aflibercept on Visual Acuity among #Patients With Macular Edema due to Central Retinal Vein Occlusion" https://t.co/r6FNGEJ9fh #ARVO2018 https://t.co/SpaNXeycKg
RT @Farmacia_AS_Pon: Bevacizumab NO INFERIOR a Aflibercept para DMAE. https://t.co/SbWpz5iHbN
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @Farmacia_AS_Pon: Bevacizumab NO INFERIOR a Aflibercept para DMAE. https://t.co/SbWpz5iHbN
RT @peacro: Alguien lo dudaba? https://t.co/lH9zS34C0L
RT @Farmacia_AS_Pon: Bevacizumab NO INFERIOR a Aflibercept para DMAE. https://t.co/SbWpz5iHbN
RT @peacro: Alguien lo dudaba? https://t.co/lH9zS34C0L
RT @Farmacia_AS_Pon: Bevacizumab NO INFERIOR a Aflibercept para DMAE. https://t.co/SbWpz5iHbN
RT @Farmacia_AS_Pon: Bevacizumab NO INFERIOR a Aflibercept para DMAE. https://t.co/SbWpz5iHbN
RT @Farmacia_AS_Pon: Bevacizumab NO INFERIOR a Aflibercept para DMAE. https://t.co/SbWpz5iHbN
RT @fararod: Por enésima vez https://t.co/6f1Tl5cfQz
Por enésima vez https://t.co/6f1Tl5cfQz
RT @Farmacia_AS_Pon: Bevacizumab NO INFERIOR a Aflibercept para DMAE. https://t.co/SbWpz5iHbN
RT @Farmacia_AS_Pon: Bevacizumab NO INFERIOR a Aflibercept para DMAE. https://t.co/SbWpz5iHbN
RT @RevistaMFSamfyc: ...debido a oclusión de la vena central de la retina. Ensayo clínico aleatorizado SCORE2 https://t.co/V3O3OHcaJM PMID…
RT @RevistaMFSamfyc: Efecto del bevacizumab frente al aflibercept sobre la agudeza visual en pacientes con edema de la mácula...https://t.c…
...debido a oclusión de la vena central de la retina. Ensayo clínico aleatorizado SCORE2 https://t.co/V3O3OHcaJM PMID 28492910
Efecto del bevacizumab frente al aflibercept sobre la agudeza visual en pacientes con edema de la mácula...https://t.co/V3O3OHtM8m 28492910
RT @peacro: Alguien lo dudaba? https://t.co/lH9zS34C0L
RT @peacro: Alguien lo dudaba? https://t.co/lH9zS34C0L
RT @peacro: Alguien lo dudaba? https://t.co/lH9zS34C0L
RT @peacro: Alguien lo dudaba? https://t.co/lH9zS34C0L
RT @peacro: Alguien lo dudaba? https://t.co/lH9zS34C0L
RT @peacro: Alguien lo dudaba? https://t.co/lH9zS34C0L
Alguien lo dudaba? https://t.co/lH9zS34C0L
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
Bevacizumab NO INFERIOR a Aflibercept para DMAE. https://t.co/SbWpz5iHbN
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
"Bevacizumab vs Aflibercept for Macular Edema Due to Retinal Vein Occlusion" https://t.co/42ZYCXDLWK
EBIO $1.42 up 7% w/$25m cash/0 debt. 24.7m OS/7.8m FL 73% inst/M.F. ownership/12.7% insider per Yahoo and 8.9 Bullish rating/good value imo https://t.co/cpYPqd6ZUK
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @JAMA_current: Which anti-VEGF agents are effective/safe for macular edema due to a central retinal or hemiretinal vein occlusion? https…
RT @JAMA_current: Which anti-VEGF agents are effective/safe for macular edema due to a central retinal or hemiretinal vein occlusion? https…
Which anti-VEGF agents are effective/safe for macular edema due to a central retinal or hemiretinal vein occlusion? https://t.co/frqU41kzHC
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
Bevacizumab vs Aflibercept for Macular Edema Due to Retinal Vein Occlusion https://t.co/zVqzNRrwQQ
RT @AndyBiotech: $REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUU…
$REGN --> $60/dose Avastin as effective as $1850/dose Eylea for treating central retinal vein occlusion https://t.co/OCUUXA0n0K
Can you say this in NHS mgr lingo please? https://t.co/LAL1L4M2pv
ICYMI All avegf about equal Again This time Bevacizumab vs Aflibercept in RVO https://t.co/eiZSgaxP2x
Bevacizumab vs Aflibercept for Macular Edema Due to Retinal Vein Occlusion https://t.co/j3AtMwm9tY
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due… https://t.co/Gon3NahD9E
RT @salbper72: Sentidiño.... https://t.co/Vaf6rj7ejL
Sentidiño.... https://t.co/Vaf6rj7ejL
#Avastin as good as #Eylea in central retinal vein occlusion, says @NatEyeInstitute #offlabeluse @Roche @regeneron https://t.co/9miJ5RpRN1
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
RT @pash22: Yup!⬆⬆opportunities for @NHSEngland to save millions & spend it on elderly & mental hlth instead @NICEcomms @Cleverestcookie @k…
Yup!⬆⬆opportunities for @NHSEngland to save millions & spend it on elderly & mental hlth instead @NICEcomms @Cleverestcookie @keithridge1 https://t.co/l7y8IqP7iX
In this non industry £ study, avastin non inf to eyela in ret vein occlusion Words like "class effect"? @pash22 https://t.co/koo9HYpbUx
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
Bevacizumab vs Aflibercept for Macular Edema Due to Retinal Vein Occlusion ➡️Beva no inferior afli... y⬆️ eficiente https://t.co/KEsgZxPDHI
Bevacizumab vs Aflibercept for Macular Edema Due to Retinal Vein Occlusion https://t.co/RlLibby3PO https://t.co/7BcjmLGryE
Bevacizumab vs Aflibercept for Macular Edema Due to Retinal Vein Occlusion. ¿Necesitamos mas? https://t.co/lXp8yF4t94
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
En JAMA: Bevacizumab vs Aflibercept for Macular Edema Due to Retinal Vein Occlusion https://t.co/shkEbUfLwn
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
RT @JAMAOphth: Bevacizumab vs Aflibercept for Macular Edema Due to Retinal Vein Occlusion https://t.co/h0oKfphsQd https://t.co/LlU57C197R
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
RT @oncology_bg: If we can have a BEVA v ZALTRAP head-to-head trial in ophthalmology, why not in oncology? @VinayPrasad82 https://t.co/JaHu…
If we can have a BEVA v ZALTRAP head-to-head trial in ophthalmology, why not in oncology? @VinayPrasad82 https://t.co/JaHuLyBOeC
Call what you want abt bevacizumab in oncology but it does seem a good (but expensive) treatment in ophthalmology. https://t.co/kqyJB7FGoE
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
Bevacizumab vs Aflibercept for Macular Edema Due to Retinal Vein Occlusion https://t.co/h0oKfphsQd https://t.co/LlU57C197R
RT @jordovas: No inferioridad de Bevacizumab vs Aflibercept en edema macular x obstrucción vascular de la retina | JAMA https://t.co/ZwQxv…
RT @JAMA_current: Which anti-VEGF agents are effective/safe for macular edema due to a central retinal or hemiretinal vein occlusion? https…